Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · IEX Real-Time Price · USD
25.65
-0.06 (-0.23%)
May 31, 2024, 4:00 PM EDT - Market closed
Anika Therapeutics Market Cap
Anika Therapeutics has a market cap or net worth of $380.35 million as of May 31, 2024. Its market cap has decreased by -4.60% in one year.
Market Cap
380.35M
Enterprise Value
338.07M
1-Year Change
-4.60%
Ranking
Category
Stock Price
$25.65
Market Cap Chart
Since December 1, 1998, Anika Therapeutics's market cap has increased from $51.20M to $380.35M, an increase of 642.87%. That is a compound annual growth rate of 8.18%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 380.30M | -0.24% |
May 30, 2024 | 381.20M | 0.26% |
May 29, 2024 | 380.20M | 3.54% |
May 28, 2024 | 367.20M | 0.80% |
May 24, 2024 | 364.30M | -0.49% |
May 23, 2024 | 366.10M | -2.84% |
May 22, 2024 | 376.80M | -1.31% |
May 21, 2024 | 381.80M | 0.42% |
May 20, 2024 | 380.20M | 0.96% |
May 17, 2024 | 376.60M | -0.40% |
May 16, 2024 | 378.10M | -2.22% |
May 15, 2024 | 386.70M | 1.90% |
May 14, 2024 | 379.50M | 0.13% |
May 13, 2024 | 379.00M | -0.29% |
May 10, 2024 | 380.10M | 1.47% |
May 9, 2024 | 374.60M | -11.27% |
May 8, 2024 | 422.20M | 0.26% |
May 7, 2024 | 421.10M | 1.79% |
May 6, 2024 | 413.70M | 0.98% |
May 3, 2024 | 409.70M | - |
May 2, 2024 | 409.70M | 4.14% |
May 1, 2024 | 393.40M | 2.31% |
Apr 30, 2024 | 384.50M | -0.31% |
Apr 29, 2024 | 385.70M | 1.58% |
Apr 26, 2024 | 379.70M | -0.05% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
LENZ Therapeutics | 390.41M |
Terns Pharmaceuticals | 388.71M |
ModivCare | 388.24M |
enGene Holdings | 387.65M |
Sonida Senior Living | 382.94M |
Biomea Fusion | 378.14M |
Esperion Therapeutics | 368.10M |
Treace Medical Concepts | 364.61M |